Pharmacokinetic study of moxalactam in patients undergoing gynecologic operations.
Moxalactam was administered prior to operation to patients undergoing operation for a known or suspected gynecologic malignancy. Subsequent plasma and tissue levels demonstrated a prolonged duration of action and rapid concentration in pelvic organs after infusion.
D000328:Adult; D000368:Aged; D005260:Female; D005833:Genital Neoplasms, Female / Q000378:metabolism / Q000601:surgery*; D006801:Humans; D007700:Kinetics; D008875:Middle Aged; D009070:Moxalactam / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control; D014018:Tissue Distribution
D009070:Moxalactam